Yan Man, Zheng Minying, Niu Rui, Yang Xiaohui, Tian Shifeng, Fan Linlin, Li Yuwei, Zhang Shiwu
Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Department of Pathology, Tianjin Union Medical Center, Tianjin, China.
Front Cell Dev Biol. 2022 Aug 17;10:938289. doi: 10.3389/fcell.2022.938289. eCollection 2022.
Metastasis, a primary cause of death in patients with malignancies, is promoted by intrinsic changes in both tumor and non-malignant cells in the tumor microenvironment (TME). As major components of the TME, tumor-associated neutrophils (TANs) promote tumor progression and metastasis through communication with multiple growth factors, chemokines, inflammatory factors, and other immune cells, which together establish an immunosuppressive TME. In this review, we describe the potential mechanisms by which TANs participate in tumor metastasis based on recent experimental evidence. We have focused on drugs in chemotherapeutic regimens that target TANs, thereby providing a promising future for cancer immunotherapy.
转移是恶性肿瘤患者死亡的主要原因,肿瘤微环境(TME)中肿瘤细胞和非恶性细胞的内在变化会促进转移。作为TME的主要组成部分,肿瘤相关中性粒细胞(TANs)通过与多种生长因子、趋化因子、炎症因子及其他免疫细胞相互作用,促进肿瘤进展和转移,共同构建免疫抑制性TME。在本综述中,我们基于近期实验证据描述了TANs参与肿瘤转移的潜在机制。我们重点关注了化疗方案中靶向TANs的药物,从而为癌症免疫治疗提供了光明前景。